Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 315.94 Million | 203.99 Million | 215.09 Million | 151.22 Million | 132.5 Million | 138.81 Million |
| Net Income | 198.31 Million | 197.34 Million | 177.27 Million | 150.04 Million | 175.29 Million | 186.32 Million |
| Depreciation & Amortization | 27.56 Million | 33.6 Million | 28.87 Million | 22.16 Million | 21.32 Million | 19.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 152.36 Million | 17.64 Million | 34.68 Million | -51.22 Million | -26.59 Million | 13.85 Million |
| Other non-cash items | -62.29 Million | -44.6 Million | -25.74 Million | 30.24 Million | -37.51 Million | -81.15 Million |
| Investing Cash Flow | 109.04 Million | -117.97 Million | -160.61 Million | -244.84 Million | -129.06 Million | -84.05 Million |
| Investments in PPE | -31.84 Million | -11.31 Million | -92.83 Million | -98.76 Million | -40.92 Million | -33.72 Million |
| Acquisitions | - | - | 798 Thousand | 1.5 Million | 25.56 Million | 465 Thousand |
| Investment purchases | -213 Million | -330 Million | -240 Million | -1.17 Billion | -1.36 Billion | -967 Million |
| Sales/Maturities of investments | 347.89 Million | 217.97 Million | 151.83 Million | 1.02 Billion | 1.26 Billion | 901.99 Million |
| Other Investing Activities | 5.99 Million | 5.36 Million | 19.59 Million | 6.2 Million | -21.75 Million | 14.21 Million |
| Financing Cash Flow | -186.45 Million | -27.71 Million | -25.19 Million | -17.75 Million | -24.39 Million | -6.84 Million |
| Debt repayment | -80 Million | - | - | -1.95 Million | - | -620 Thousand |
| Dividends payments | -283.67 Million | -28.21 Million | -26.35 Million | -15.87 Million | -28.79 Million | -31.33 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 17.21 Million | 504 Thousand | 1.15 Million | 76 Thousand | 4.4 Million | 25.11 Million |
| Accounts receivables | 22.65 Million | -51.44 Million | 14.56 Million | -26.85 Million | -10.5 Million | -43.54 Million |
| Accounts payables | - | 51.44 Million | -14.56 Million | 26.85 Million | 10.5 Million | - |
| Inventory | 20.4 Million | -51.71 Million | -13.93 Million | -3.88 Million | 3.63 Million | -2.82 Million |
| Other working capital | 131.95 Million | 69.35 Million | 48.62 Million | -47.34 Million | -30.22 Million | 16.68 Million |
| Cash at beginning of period | 113.6 Million | 55.29 Million | 26.01 Million | 137.38 Million | 158.34 Million | 110.42 Million |
| Cash at end of period | 352.13 Million | 113.6 Million | 55.29 Million | 26.01 Million | 137.38 Million | 158.34 Million |
| Capital Expenditure | -31.84 Million | -11.31 Million | -92.83 Million | -98.76 Million | -40.92 Million | -33.72 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 238.53 Million | 58.3 Million | 29.27 Million | -111.37 Million | -20.95 Million | 47.91 Million |
| Free Cash Flow | 284.1 Million | 192.67 Million | 122.25 Million | 52.46 Million | 91.58 Million | 105.09 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 52.14 Million | 52.14 Million | 14.91 Million | 198.31 Million | 52.44 Million | 28.46 Million |
| Depreciation & Amortization | - | - | - | 27.56 Million | - | 36.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 152.36 Million | - | - |
| Other non-cash items | -52.14 Million | -52.14 Million | -14.91 Million | -62.29 Million | -52.44 Million | -28.46 Million |
| Investing Cash Flow | - | - | - | 109.04 Million | - | - |
| Investments in PPE | - | - | - | -31.84 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -213 Million | - | - |
| Sales/Maturities of investments | - | - | - | 347.89 Million | - | - |
| Other Investing Activities | - | - | - | 5.99 Million | - | - |
| Financing Cash Flow | - | - | - | -186.45 Million | - | - |
| Debt repayment | - | - | - | -80 Million | - | - |
| Dividends payments | - | - | - | -283.67 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 17.21 Million | - | - |
| Accounts receivables | - | - | - | 22.65 Million | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | 20.4 Million | - | - |
| Other working capital | - | - | - | 131.95 Million | - | - |
| Cash at beginning of period | - | - | - | 113.6 Million | - | 127.54 Million |
| Cash at end of period | - | - | - | 352.13 Million | - | 101.23 Million |
| Capital Expenditure | - | - | - | -31.84 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | 238.53 Million | - | -26.3 Million |
| Free Cash Flow | - | - | - | 284.1 Million | - | 73.9 Million |
OILS
KPEL
600984
MGXMF
000546
SAR